Digital therapy for chronic pain and insomnia
Digital CBT-I for Patients With Chronic Pain and Insomnia (The Back2Sleep Trial). A Randomized Controlled Trial
This study is trying out a digital therapy program to see if it can help people with chronic pain and insomnia sleep better and feel less pain.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 1 site (Odense) |
| Trial ID | NCT06361914 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a digital cognitive behavioral therapy for insomnia (CBT-I) program in patients suffering from chronic pain and insomnia. Participants will be randomly assigned to either the digital CBT-I group or a sleep hygiene education group, both utilizing the Hvil® app for a duration of 9 weeks. The aim is to assess improvements in sleep quality and reductions in pain intensity through a randomized controlled trial design. Data will be collected via online questionnaires, ensuring a comprehensive evaluation of treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who experience chronic pain for at least three months and have comorbid insomnia.
Not a fit: Patients who do not have chronic pain or insomnia, or those who cannot access a smartphone, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide an accessible and effective non-pharmacological treatment option for patients with chronic pain and insomnia.
How similar studies have performed: Previous studies have shown that digital CBT-I can be effective, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: For a participant to be eligible, all inclusion criteria must be answered "yes": * Age ≥ 18 years. * Understand and write Danish. * Have smartphone access. * Pain for 3 months or longer. * Pain must be present on 'most days' or 'every day' within the past 3 months (will be checked by the question: 'In the past 3 months, how often did you have pain? - response options: 'never'; 'some days'; 'most days'; 'every day'). * Pain must limit life or work activities on 'some days', 'most days', or 'every day' within the past 3 months (will be checked by the question: 'In the past 3 months, how often did your pain limit your life or work activities - response options: never, some days, most days, every day * Average pain intensity equal to or higher than 4 on a 0-10 Numeric Rating Scale \[NRS\] in the past 7 days (ranging from 'no pain' to 'worst imaginable pain'). Insomnia symptoms (Insomnia Severity Index (ISI) score \> 10; moderate insomnia). Exclusion Criteria: For a participant to be eligible, all exclusion criteria must be answered "no": * Pregnancy or lactation (Pregnancy is screened for through self-reporting as no risks regarding pregnancy have been identified for the described study procedures). * Does not have daily assess to smartphone/tablet * Night shift during the time of the CBT-I treatment. * Currently receiving pharmacological treatment for insomnia (e.g. benzodiazepines, hypnotics etc.). * Severe psychiatric/somatic illnesses of relevance of their sleep (reported by participant). * Diagnosed sleep disorders (e.g., OSA, narcolepsy). * Does not have E-boks. * Known abuse of alcohol or other substances. * Suicide and self-harm thoughts (reported by participant). * People judged incapable, by the investigator, of understanding the participant instruction or who are not capable of carrying through the investigation. For the EEG subgroup only (60 patients): * Age ≥ 65 years * Anatomy of the outer ear making it impossible to do ear EEG monitoring. * Ear piercings that are not compatible with ear EEG. * Previous stroke or cerebral haemorrhage and any other structural cerebral disease. * Teeth grinding (bruxism). * Allergic contact dermatitis caused by metals or generally prone to skin irritation.
Where this trial is running
Odense
- Pain Center, Department of Anesthesiology and Intensive Care Medicine, University Hospital Odense — Odense, Denmark (Recruiting)
Study contacts
- Principal investigator: Henrik B Vægter, PhD — University Hospital Odense
- Study coordinator: Henrik B Vaegter, PhD
- Email: hbv@rsyd.dk
- Phone: 004565413869
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.